Geode Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 5,813,036 shares of VRTX stock, worth $2.72 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares

5,813,036

Previous 5,673,419 2.46%

Holding current value

$2.72 Billion

Previous $2.31 Billion 5.26%

% of portfolio

0.23%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $56.9 Million - $62.3 Million	139,617 Added 2.46%	5,813,036 $2.43 Billion
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $26.6 Million - $31.8 Million	77,445 Added 1.38%	5,673,419 $2.31 Billion
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $17.3 Million - $18.5 Million	51,113 Added 0.92%	5,595,974 $1.95 Billion
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $42.6 Million - $47.7 Million	135,604 Added 2.51%	5,544,861 $1.95 Billion
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $7.52 Million - $8.57 Million	26,538 Added 0.49%	5,409,257 $1.7 Billion

Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $31.7 Million - $35.7 Million	111,052 Added 2.11%	5,382,719 $1.55 Billion
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $202 Million - $225 Million	737,183 Added 16.26%	5,271,667 $1.52 Billion
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $48 Million - $59.8 Million	204,253 Added 4.72%	4,534,484 $1.28 Billion
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $5.75 Million - $6.78 Million	-25,989 Reduced 0.6%	4,330,231 $1.13 Billion
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $9.54 Million - $12 Million	53,868 Added 1.25%	4,356,220 $954 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $39 Million - $43.7 Million	215,173 Added 5.26%	4,302,352 $778 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $27.4 Million - $32.3 Million	145,993 Added 3.7%	4,087,179 $822 Million
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $11.3 Million - $13.1 Million	54,343 Added 1.4%	3,941,186 $845 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $2.63 Million - $3.5 Million	12,691 Added 0.33%	3,886,843 $916 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $8.65 Million - $10.3 Million	33,835 Added 0.88%	3,874,152 $1.05 Billion
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $6.98 Million - $9.15 Million	30,946 Added 0.81%	3,840,317 $1.11 Billion
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $47.4 Million - $58.8 Million	237,183 Added 6.64%	3,809,371 $905 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $19.2 Million - $25.8 Million	115,110 Added 3.33%	3,572,188 $780 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $18 Million - $20.3 Million	108,297 Added 3.23%	3,457,078 $585 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $18.6 Million - $21.6 Million	113,284 Added 3.5%	3,348,781 $613 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $28.8 Million - $34.3 Million	176,191 Added 5.76%	3,235,497 $594 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $31.6 Million - $40 Million	207,934 Added 7.29%	3,059,306 $506 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $11.7 Million - $13.5 Million	69,858 Added 2.51%	2,851,372 $548 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $7.06 Million - $8.24 Million	48,459 Added 1.77%	2,781,514 $472 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $19.1 Million - $22.3 Million	125,804 Added 4.83%	2,733,055 $444 Million
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $14.5 Million - $16.4 Million	105,683 Added 4.22%	2,607,251 $390 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $16.9 Million - $18.5 Million	114,200 Added 4.78%	2,501,568 $380 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,387,368	2,387,368 $307 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History